6.
Ettehad D, Emdin C, Kiran A, Anderson S, Callender T, Emberson J
. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016; 387(10022):957-967.
DOI: 10.1016/S0140-6736(15)01225-8.
View
7.
Mc Auley M, Mooney K
. LDL-C levels in older people: Cholesterol homeostasis and the free radical theory of ageing converge. Med Hypotheses. 2017; 104:15-19.
DOI: 10.1016/j.mehy.2017.05.013.
View
8.
Gencer B, Marston N, Im K, Cannon C, Sever P, Keech A
. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2020; 396(10263):1637-1643.
PMC: 8015314.
DOI: 10.1016/S0140-6736(20)32332-1.
View
9.
Boren J, Chapman M, Krauss R, Packard C, Bentzon J, Binder C
. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020; 41(24):2313-2330.
PMC: 7308544.
DOI: 10.1093/eurheartj/ehz962.
View
10.
DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J
. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53.
DOI: 10.1161/CIRCULATIONAHA.107.699579.
View
11.
Benfante R, Reed D, MacLean C, Yano K
. Risk factors in middle age that predict early and late onset of coronary heart disease. J Clin Epidemiol. 1989; 42(2):95-104.
DOI: 10.1016/0895-4356(89)90082-6.
View
12.
Tchkonia T, Kirkland J
. Aging, Cell Senescence, and Chronic Disease: Emerging Therapeutic Strategies. JAMA. 2018; 320(13):1319-1320.
DOI: 10.1001/jama.2018.12440.
View
13.
Aggarwal D, Kathariya M, Verma D
. LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker. Indian Heart J. 2021; 73(5):544-548.
PMC: 8514398.
DOI: 10.1016/j.ihj.2021.07.013.
View
14.
Jeong S, Choi S, Kim K, Kim S, Lee G, Park S
. Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults. J Am Heart Assoc. 2018; 7(12).
PMC: 6220545.
DOI: 10.1161/JAHA.118.008819.
View
15.
Nordestgaard B, Chapman M, Humphries S, Ginsberg H, Masana L, Descamps O
. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013; 34(45):3478-90a.
PMC: 3844152.
DOI: 10.1093/eurheartj/eht273.
View
16.
Martin S, Blaha M, Elshazly M, Brinton E, Toth P, McEvoy J
. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol. 2013; 62(8):732-9.
DOI: 10.1016/j.jacc.2013.01.079.
View
17.
Kronenberg F
. Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region. Clin Res Cardiol Suppl. 2019; 14(Suppl 1):5-12.
DOI: 10.1007/s11789-019-00093-5.
View
18.
Kannel W, DAWBER T, Friedman G, GLENNON W, MCNAMARA P
. RISK FACTORS IN CORONARY HEART DISEASE. AN EVALUATION OF SEVERAL SERUM LIPIDS AS PREDICTORS OF CORONARY HEART DISEASE; THE FRAMINGHAM STUDY. Ann Intern Med. 1964; 61:888-99.
DOI: 10.7326/0003-4819-61-5-888.
View
19.
Milane A, Abdallah J, Kanbar R, Khazen G, Ghassibe-Sabbagh M, Salloum A
. Association of hypertension with coronary artery disease onset in the Lebanese population. Springerplus. 2014; 3:533.
PMC: 4176843.
DOI: 10.1186/2193-1801-3-533.
View
20.
Wu C, Hu H, Chou Y, Huang N, Chou Y, Li C
. High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults. Medicine (Baltimore). 2015; 94(47):e2160.
PMC: 5059018.
DOI: 10.1097/MD.0000000000002160.
View